Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is 84.81 as of 2026-10-06T13:35:39.781Z.
Consensus retrieved: 2026-10-06T09:14:06.032Z. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T13:35:39.781Z.
Quote observation: 2026-10-06T13:35:07.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 3053ee84cf6af561b07b3dfb120285cda481bce56d3c16a917f081021098493d
Forward PE Ratio (84.81) = Dated Quote Price ($37.53) / Consensus Forward EPS ($0.44)
FORWARD PE RATIO
84.81
SECTOR MEDIAN · HEALTHCARE
19.26
median of 146 covered companies
CURRENT VS SECTOR MEDIAN
+340.34%
vs the sector median at left
AxoGen, Inc.
Market Cap
$2.02B
Forward PE Ratio
84.81
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| AxoGen, Inc. (AXGN) | $2.02B | 84.81 |
| Aurinia Pharmaceuticals Inc. (AUPH)vs › | $2.02B | 16.66 |
| Alvotech (ALVO)vs › | $2.04B | N/A |
| Absci Corporation (ABSI)vs › | $1.99B | N/A |
| Immunome, Inc. (IMNM)vs › | $1.99B | N/A |
| Azenta, Inc. (AZTA)vs › | $2.05B | 89.38 |
| BioCryst Pharmaceuticals, Inc. (BCRX)vs › | $2.05B | N/A |
| Establishment Labs Holdings Inc. (ESTA)vs › | $1.99B | N/A |
| Inspire Medical Systems, Inc. (INSP)vs › | $2.07B | 59.90 |
| Addus HomeCare Corporation (ADUS)vs › | $2.12B | 16.16 |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
84.8
consensus EPS · fiscal year ending 2026-12-31
At the dated quote price of $37.53, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $0.44 | $0.41 – $0.47 | 5 | 84.8x |
| 2027-12-31 | $0.69 | $0.65 – $0.73 | 5 | 54.2x |
| 2028-12-31 | $1.02 | $-0.25 – $2.09 | 6 | 36.9x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
